(Q74586905)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

randomized controlled trial

11 November 2019

main subject

1 reference

A Castro-Guardiola

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A L Viejo-Rodríguez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S Soler-Simon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Armengou-Arxé

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

V Bisbe-Company

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

G Peñarroja-Matutano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Bisbe-Company

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

F García-Bragado

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

367-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

Community-acquired pneumonia: the annual cost to the National Health Service in the UK.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Practical considerations and guidelines for the management of community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Community-acquired pneumonia in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

A prediction rule to identify low-risk patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Identification of low-risk hospitalized patients with pneumonia. Implications for early conversion to oral antimicrobial therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Evaluation of a pneumonia practice guideline in an interventional trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Parenteral Followed by Oral Ofloxacin for Nosocomial Pneumonia and Community-acquired Pneumonia Requiring Hospitalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Early Switch From Intravenous to Oral Antibiotics and Early Hospital Discharge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Antibiotic therapy in pneumonia: a comparative study of parenteral and oral administration of penicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Infusion phlebitis in patients with acute pneumonia: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

Patients hospitalized after initial outpatient treatment for community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900868-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(01)00868-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11583639%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference